Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2011, Article ID 791013, 5 pages
http://dx.doi.org/10.4061/2011/791013
Case Report

Liver Resection after Downstaging Hepatocellular Carcinoma with Sorafenib

1Department of Digestive Surgery and Liver Transplantation, Rangueil Hospital, 1 avenue du Professor Jean Poulhès, 31059 Toulouse Cedex 9, France
2Department of Pathology, Rangueil Hospital, 31059 Toulouse, France
3Department of Hepato-Gastro-Enterology, Pau Hospital, 4 Boulevard Hauterive, 64046 Pau, France
4Department of Radiology, Rangueil Hospital, 31059 Toulouse, France

Received 20 October 2010; Accepted 24 January 2011

Academic Editor: Ryosuke Tateishi

Copyright © 2011 L. Barbier et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • J. Y. Lei, and L. N. Yan, “Comparison Between Living Donor Liver Transplantation Recipients Who Met the Milan and UCSF Criteria After Successful Downstaging Therapies,” Journal Of Gastrointestinal Surgery, vol. 16, no. 11, pp. 2120–2125, 2012. View at Publisher · View at Google Scholar
  • M. Guba, M. Angele, M. Rentsch, K. W. Jauch, R. Zachoval, F. Kolligs, A. Gerbes, and C. J. Bruns, “Therapy of hepatocellular carcinoma before liver transplantation,” Chirurg, vol. 84, no. 5, pp. 385–390, 2013. View at Publisher · View at Google Scholar
  • T. Waddell, and D. Cunningham, “Impact of targeted neoadjuvant therapies in the treatment of solid organ tumours,” British Journal Of Surgery, vol. 100, no. 1, pp. 5–14, 2013. View at Publisher · View at Google Scholar
  • Aude Di Fiore, Fanny Drieux, Frederic Di Fiore, Michel Scotte, Sabrina Kermiche-Rahali, and Arnaud Francois, “Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib,” World Journal Of Surgical Oncology, vol. 11, 2013. View at Publisher · View at Google Scholar
  • Louise Barbier, David Fuks, Patrick Pessaux, Sandrine Faivre, Fabrice Muscari, Yves-Patrice Le Treut, and Jacques Belghiti, “Safety of Liver Resection for Hepatocellular Carcinoma After Sorafenib Therapy: A Multicenter Case-Matched Study,” Annals Of Surgical Oncology, vol. 20, no. 11, pp. 3603–3609, 2013. View at Publisher · View at Google Scholar
  • Seiji Oguro, Satoshi Nara, Shunsuke Kondo, Shutaro Hori, Yoji Kishi, Minoru Esaki, Kazuaki Shimada, Tomoo Kosuge, Takuji Okusaka, and Hidenori Ojima, “A Case of Pathological Complete Response after Combination Chemotherapy by Sorafenib and Cisplatin Hepatic Arterial Infusion for an Advanced Hepatocellular Carcinoma,” The Japanese Journal of Gastroenterological Surgery, vol. 46, no. 12, pp. 915–923, 2013. View at Publisher · View at Google Scholar
  • Kasper Jarlhelt Andersen, Anders Riegels Knudsen, Anne-Sofie Kannerup, Jens Randel Nyengaard, Stephen Hamilton-Dutoit, Morten Ladekarl, and Frank Viborg Mortensen, “Postoperative but not preoperative treatment with Sorafenib inhibits liver regeneration in rats,” Journal of Surgical Research, 2014. View at Publisher · View at Google Scholar
  • Rebecca M. Dodson, Jin He, and Timothy M. Pawlik, “Cellular communication via microparticles: role in transfer of multidrug resistance in cancer,” Future Oncology, vol. 10, no. 4, pp. 587–607, 2014. View at Publisher · View at Google Scholar
  • Yu Zhang, Zhi-Long Shi, Xia Yang, and Zheng-Feng Yin, “Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis,” World Journal of Gastroenterology, vol. 20, no. 1, pp. 142–147, 2014. View at Publisher · View at Google Scholar
  • Toshihiro Kitajima, Etsuro Hatano, Yusuke Mitsunori, Kojiro Taura, Yasuhiro Fujimoto, Masaki Mizumoto, Hideaki Okajima, Toshimi Kaido, Sachiko Minamiguchi, and Shinji Uemoto, “Complete pathological response induced by sorafenib for advanced hepatocellular carcinoma with multiple lung metastases and venous tumor thrombosis allowing for curative resection,” Clinical Journal of Gastroenterology, 2015. View at Publisher · View at Google Scholar
  • Kenichi Nakamura, Toru Beppu, Hiromitsu Hayashi, Hirohisa Okabe, Kastunori Imai, Hidetoshi Nitta, Akira Chikamoto, Takatoshi Ishiko, Masato Sasaki, and Hideo Baba, “Recurrence-Free Survival of a Hepatocellular Carcinoma Patient With Tumor Thrombosis of the Inferior Vena Cava After Treatment With Sorafenib and Hepatic Resection,” International Surgery, vol. 100, no. 5, pp. 908–914, 2015. View at Publisher · View at Google Scholar
  • Matthew Quirk, “Management of hepatocellular carcinoma with portal vein thrombosis,” World Journal of Gastroenterology, vol. 21, no. 12, pp. 3462, 2015. View at Publisher · View at Google Scholar
  • Hyun Young Woo, and Jeong Heo, “New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis,” Clinical and Molecular Hepatology, vol. 21, no. 2, pp. 115, 2015. View at Publisher · View at Google Scholar
  • Hai-Hong Ye, Jia-Zhou Ye, Zhi-Bo Xie, Yu-Chong Peng, Jie Chen, Liang Ma, Tao Bai, Jun-Ze Chen, Zhan Lu, Hong-Gui Qin, Bang-De Xiang, and Le-Qun Li, “Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein,” World Journal Of Gastroenterology, vol. 22, no. 13, pp. 3632–3643, 2016. View at Publisher · View at Google Scholar
  • Dario Lorenzin, Riccardo Pravisani, Cosimo Alex Leo, Walter Bugiantella, Giorgio Soardo, Alessia Carnelutti, Baccarani Umberto, and Andrea Risaliti, “Complete Remission of Unresectable Hepatocellular Carcinoma After Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization,” Cancer Biotherapy and Radiopharmaceuticals, vol. 31, no. 2, pp. 65–69, 2016. View at Publisher · View at Google Scholar
  • Yadi Liao, Yunfei Yuan, Yun Zheng, Wei He, Qijiong Li, Jingxian Shen, Jian Hong, Ruhai Zou, Jiliang Qiu, and Binkui Li, “Sorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence.,” Oncology letters, vol. 13, no. 2, pp. 984–992, 2017. View at Publisher · View at Google Scholar